IUHC.L vs. BTEE.L
IUHC.L (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) and BTEE.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) are both Health & Biotech Equities funds from iShares - IUHC.L tracks the S&P 500 Capped 35/20 Health Care Index while BTEE.L tracks the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 5 years, IUHC.L returned 5.75%/yr vs 4.70%/yr for BTEE.L. A 0.68 correlation means they provide meaningful diversification when combined. IUHC.L charges 0.15%/yr vs 0.35%/yr for BTEE.L.
Performance
IUHC.L vs. BTEE.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IUHC.L achieves a -2.09% return, which is significantly lower than BTEE.L's 4.58% return.
IUHC.L
- 1D
- 3.00%
- 1M
- 4.72%
- YTD
- -2.09%
- 6M
- -0.45%
- 1Y
- 15.03%
- 3Y*
- 6.58%
- 5Y*
- 5.75%
- 10Y*
- 9.20%
BTEE.L
- 1D
- 3.30%
- 1M
- 1.17%
- YTD
- 4.58%
- 6M
- 3.18%
- 1Y
- 41.45%
- 3Y*
- 13.12%
- 5Y*
- 4.70%
- 10Y*
- —
IUHC.L vs. BTEE.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
IUHC.L iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) | -2.09% | 14.67% | 2.16% | 1.72% | -2.63% | 27.58% | 11.93% | 20.60% | 2.30% |
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 4.58% | 32.82% | -1.69% | 5.84% | -11.88% | -0.57% | 27.55% | 25.56% | -14.84% |
Correlation
The correlation between IUHC.L and BTEE.L is 0.67, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.67 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.62 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.64 |
Correlation (All Time) Calculated using the full available price history since Mar 9, 2018 | 0.68 |
The correlation between IUHC.L and BTEE.L has been stable across timeframes, ranging from 0.62 to 0.68 - a consistent structural relationship.
IUHC.L vs. BTEE.L - Sectors Allocation Comparison
Sectors
IUHC.L
BTEE.L
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IUHC.L
BTEE.L
Basic Materials
IUHC.L
-
BTEE.L
-
Communication Services
IUHC.L
-
BTEE.L
-
Consumer Cyclical
IUHC.L
-
BTEE.L
-
Consumer Defensive
IUHC.L
-
BTEE.L
-
Energy
IUHC.L
-
BTEE.L
-
Financial Services
IUHC.L
-
BTEE.L
-
Industrials
IUHC.L
-
BTEE.L
-
Real Estate
IUHC.L
-
BTEE.L
-
Technology
IUHC.L
-
BTEE.L
-
Utilities
IUHC.L
-
BTEE.L
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IUHC.L vs. BTEE.L — Risk / Return Rank
IUHC.L
BTEE.L
IUHC.L vs. BTEE.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IUHC.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IUHC.L | BTEE.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.10 | ||
| Sortino ratioReturn per unit of downside risk | -1.41 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.35 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | 1.43 | 5.41 | -3.97 |
| Martin ratioReturn relative to average drawdown | 3.57 | 16.70 | -13.13 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IUHC.L | BTEE.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.00 | 2.10 | -1.10 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.39 | 0.22 | +0.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.58 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.56 | 0.30 | +0.26 |
Drawdowns
IUHC.L vs. BTEE.L - Drawdown Comparison
The maximum IUHC.L drawdown since its inception was -27.44%, smaller than the maximum BTEE.L drawdown of -38.29%. Use the drawdown chart below to compare losses from any high point for IUHC.L and BTEE.L.
Loading charts...
Drawdown Indicators
| IUHC.L | BTEE.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -27.44% | -38.29% | +10.85% |
Max Drawdown (1Y)Largest decline over 1 year | -10.44% | -7.63% | -2.81% |
Max Drawdown (3Y)Largest decline over 3 years | -17.63% | -26.82% | +9.19% |
Max Drawdown (5Y)Largest decline over 5 years | -17.63% | -38.29% | +20.66% |
Max Drawdown (10Y)Largest decline over 10 years | -27.44% | — | — |
Current DrawdownCurrent decline from peak | -4.57% | -2.58% | -1.99% |
Average DrawdownAverage peak-to-trough decline | -4.90% | -13.56% | +8.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.20% | 2.47% | +1.73% |
Volatility
IUHC.L vs. BTEE.L - Volatility Comparison
The current volatility for iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IUHC.L) is 4.89%, while iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) has a volatility of 6.84%. This indicates that IUHC.L experiences smaller price fluctuations and is considered to be less risky than BTEE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IUHC.L | BTEE.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.89% | 6.84% | -1.95% |
Volatility (6M)Calculated over the trailing 6-month period | 10.81% | 15.33% | -4.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.00% | 19.63% | -4.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.82% | 21.14% | -6.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.71% | 22.50% | -6.79% |
IUHC.L vs. BTEE.L - Expense Ratio Comparison
IUHC.L has a 0.15% expense ratio, which is lower than BTEE.L's 0.35% expense ratio.
Dividends
IUHC.L vs. BTEE.L - Dividend Comparison
IUHC.L has not paid dividends to shareholders, while BTEE.L's dividend yield for the trailing twelve months is around 0.36%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.36% | 0.37% | 0.46% | 0.39% | 0.44% | 0.25% | 0.17% | 0.14% | 0.07% |
IUHC.L iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
IUHC.L and BTEE.L have a correlation of 0.67, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IUHC.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IUHC.L is cheaper with a 0.15% expense ratio, compared with 0.35% for BTEE.L.
IUHC.L tracks S&P 500 Capped 35/20 Health Care Index, while BTEE.L tracks NASDAQ Biotechnology TR USD. Their fees differ too: 0.15% for IUHC.L and 0.35% for BTEE.L.
Find the right allocation for IUHC.L and BTEE.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer